Text Size

Low-Cost Contingency Management for Hispanic Outpatients - 3

This study has been completed.
Sponsor:
Collaborator:
University of Connecticut Health Center
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00249548
First received: November 3, 2005
Last updated: May 23, 2008
Last verified: May 2008
History of Changes

November 3, 2005
May 23, 2008
August 2004
January 2006   (final data collection date for primary outcome measure)
Drug use [ Time Frame: baseline and each follow-up ] [ Designated as safety issue: No ]
Drug use
Complete list of historical versions of study NCT00249548 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Low-Cost Contingency Management for Hispanic Outpatients - 3
Low-Cost Contingency Management for Hispanic Outpatients

The purpose of this study is to evaluate the effectiveness of a lower-cost contingency management (CM) procedure in Hispanic substance abusing outpatients. Thirty individuals meeting DSM-IV criteria for substance dependence receive one of two conditions: (a) standard treatment, or (b) standard treatment plus prize CM. Using a cross-over design, CM is implemented in a community-based outpatient clinic and compared with non-CM in the same clinic. The participating clinic is randomly assigned to receive either the CM or non-CM phase first; 15 weeks after the final participant in one phase is enrolled, a one-week washout period occurs, followed by a switch to the other phase. Patients initiating outpatient treatment during the non-CM phase receive standard treatment and submit urine and breath samples 2/week during Weeks 1-6 and 1/week during Weeks 7-12. Patients initiating treatment during the CM phase also receive standard treatment and the same breath and urine monitoring. In addition, they earn the opportunity to win prizes for coming to treatment and for submitting negative breath and urine samples. Follow-up interviews are conducted at 1,3,6 and 9 months following intake during which substance use and psychosocial functioning are assessed.
Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Substance Abuse
Behavioral: Contingency management
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
30
January 2006
January 2006   (final data collection date for primary outcome measure)

Inclusion criteria:

  • age > 18 years
  • current DSM-IV substance dependence.

Exclusion criteria:

  • have a serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, severe or psychotic major depression, or suicide risk) on the basis of history or medical examination
  • have dementia (<23 on the Mini Mental State Exam; Folstein et al. 1975)
  • DSM-IV diagnosis of pathological gambling
  • plans to move from the Hartford are within 9 months.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00249548
NIDA-13444-3, R01-13444-3
No
Nancy Petry, Ph.D., UConn Health Center
National Institute on Drug Abuse (NIDA)
University of Connecticut Health Center
Principal Investigator: Nancy Petry, Ph.D. University of Connecticut Health Center
National Institute on Drug Abuse (NIDA)
May 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP